Sarcoma  >>  Erbitux (cetuximab)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Erbitux (cetuximab) / Eli Lilly, EMD Serono
ESTER, NCT03914170: Folfirinox + Cetuximab Chemotherapy, in First Line, With Wild RAS and According to BRAF Status in Metastatic Colorectal Cancer

Completed
N/A
70
Europe
Folfirinox + cetuximab
Institut du Cancer de Montpellier - Val d'Aurelle, Merck Serono International SA
Colorectal Cancer
04/18
04/18

Download Options